U.S. Requirements for Dietary Supplement Ingredients and USP <2232> Elemental Impurities Is Your Company Ready for Implementation?

Similar documents
General Chapter/Section: <232> Elemental Impurities - Limits Expert Committee(s): General Chapters Chemical Analysis No.

USP Perspective on Atypical Actives November 29, 2017

Residual Solvents: FDA/ Regulatory Perspective

USP <232> and <233> Understanding Your Path to Compliance with the New Elemental Impurity Chapters. Steve Wall Agilent Technologies

232 ELEMENTAL IMPURITIES LIMITS

Recent Evolution of Monographs for Dietary Supplements in USP

Converting between PDEs and Concentration Limits

Understanding New USP Chapter <2232> for Trace Elemental Contaminants in Dietary Supplements and Nutraceutical Products

Overview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017

Expectations for Implementation in Europe

PQRI/USP Workshop on ICH Q3D Elemental Impurities Requirements Recent Experience and Plans for Full Implementation in 2018

Actual Excipient Test Data on Metal Impurities Submitted to IPEC-Americas from Industry

Janeen A. Skutnik-Wilkinson ICH Topic co-creator EWG Team Member

NDI: LOOKING BACK & AHEAD

FOOD AND DRUGS AUTHORITY (FDA) GHANA

ICH guideline Q3D (R1) on elemental impurities

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

Organic Impurities in Drug Substances and Drug Products. Antonio Hernandez-Cardoso, M.Sc. Senior Scientific Liaison September 8, 2017

COMMENTS. Submitted by The International Pharmaceutical Aerosol Consortium

Guidance on Limits of Foreign Matter in Herbal Ingredients

Southern California Section & Western Compendial Discussion Group

Legal Requirements for the Control of Contaminants in Herbal Medicinal Products and Related Areas

FDA s Food Additives Program

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

Listing of Color Additives Exempt from Certification; Synthetic Iron Oxide

Citric Acid, Monohydrate

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

Overview of Regulatory Science of Food Contact Substances

USP Dietary Supplements Standards Up-to-Date Roundtable Meeting Report. Huy Dinh, MS. Senior Scientific Liaison Dietary Supplements

OFF All Dr. Clark Cleanses

MEDICNES CONTROL AGENCY GUIDELINE FOR REGISTRATION OF HERBAL MEDICINAL PRODUCTS IN THE GAMBIA

Taylor C. Wallace, PhD, CFS, FACN, March 22, 2018

Current FDA Perspective on Excipients NJPhAST Meeting September 15, 2016

Emanuela Turla Scientific Officer Nutrition Unit - EFSA

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES (TM) AND HEALTH SUPPLEMENTS (HS)

Ornsurang Teerawat

A Modern Approach to Excipient Quality Assurance

SelenoExcell Food & Beverage Product Guide

TOBACCO PRODUCT OR MEDICAL PRODUCT?

USP Excipients Standards Setting Process

Raritan Pharmaceuticals, Inc. 6/20/17

FOOD CONTACT COATINGS --- A MANUFACTURER S PERSPECTIVE

Re: National Bioengineered Food Disclosure Standard; Proposed Rule; Request for Comments, 83 Fed. Reg (May 4, 2018), Docket No.

Co-processed Excipient Guide

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

IPEC Europe Suggested Alternative (if none then original text is clear and needs no alteration) Purpose and Scope

FDA Food Contact Fundamentals

Lactose, Monohydrate

Proposed FDA Food Safety Modernization Act:

Food Additives Program

MULTI-COMPONENT ANALYSIS OF HEAVY METALS

SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive

USP botanical quality standards: contributions in quality control & safe use of botanicals

UNICEF Micronutrient Powder Specification

Disclosure. Objectives. Objectives. Introduction. Introduction. Non-Sterile Compounding/Calculations

2014 FDA/JIFSAN Food & Nutrition Webinar

Overview of Dietary Supplement GMP Inspection Trends Quality Session 6

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

FDA Food Safety Modernization Act (FSMA) January 4, 2011

Prof. Marina Heinonen University of Helsinki Member of the NDA Panel and EFSA s WG on Novel Foods

OLIN CORPORATION SALES SPECIFICATION

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

Analytical method validation. Presented by Debbie Parker 4 July, 2016

U.S. FDA Perspective on Food Supplements/TM

Via RE: 2014 Draft National Food Safety Standard General Standard for Sports Nutrition Food

Food Commissaries under FSMA and the US FDA model Food Code

16 February Cannabis Standards and their relationship to Clinical Health Outcomes

FSMA & The Dietary Supplements Industry

GMP GMP. What is it and why do we need it? Dennis Reiswig. The FDA. USP & NF History. Regulatory Definitions. (Good Manufacturing Practices)

Module 34: Legal aspects, ADI and GRAS status of food additives

Citric Acid Monohydrate

247 CMR BOARD OF REGISTRATION IN PHARMACY

ACTION: Notification; declaratory order; extension of compliance date.

Political Economy of the Medical Products Industry

in the ICH Regions Table of Content Annexes to Guideline and 3. Why is Q4B necessary? Q4B Annexes? for Human Use

Frequently Asked Questions by HPs to NCs

Food Safety Modernization Act - Impacts on the Grain and Feed Industry

Analysis of trace elements in nutraceuticals in compliance with USP chapter <2232> Elemental Contaminants in Dietary Supplements

December 4, 2017 VIA ELECTRONIC SUBMISSION

AKA Good Manufacturing Practice (GMP) Certification Program

Applying Risk Assessment Outcomes to Establish Food Standards

Guideline on quality of herbal medicinal products 1 /traditional herbal medicinal products

Compounding Medication Regulations

Client Alert. FDA Draft Guidance Broadens New Dietary Ingredient Definition and Extends Notification Requirements 1

H e r b a l M e dicines' Q U A L I T Y M ANUAL. I. Introduction

Final Rule for Preventive Controls for Animal Food

Safety Assessment of Botanicals and Botanical Preparations. Dr. Balasubramanian

Purpose of this Document

Sodium Acetate, Anhydrous

Compare Results. 153 Replacements 26 Insertions 344 Deletions. Total Changes. Styling and. Content. 0 Annotations. Old File: New File:

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

July 27-30, th Annual Meeting of the Poultry Science Association Louisville, Kentucky. Presented at:

Putting the Nutritional Supplement Industry to the Test: Looking for Transparency

Safety Evaluation for Substances Directly Added to Food

memorandum Venable s FDA Practice Group FDA Publishes Draft Guidance on New Dietary Ingredients ( NDIs )

A New USP Tool The Class Monograph

Excipient Risk Assessment

The Complexity of Setting Compendial Specifications for Excipient Composition and Impurities

Transcription:

U.S. Requirements for Dietary Supplement Ingredients and USP <2232> Elemental Impurities Is Your Company Ready for Implementation? Priscilla Zawislak NIA-West, Ojai, CA May 28, 2015 1 Outline Ø U.S. Regulatory Requirements for Ingredients in Dietary Supplements FDA and Compendial Requirements Ø USP <2232> Elemental Contaminants in Dietary Supplements Is Your Company Ready for Implementation? Background Challenges Current Industry Needs 2 1

FD&C Act - Dietary Supplement Ingredients U.S. Food Drug & Cosmetic Act, Sec. 201. [21 U.S.C. 321] Chapter 9, Subchapter II Definitions: (ff) a dietary supplement shall be deemed to be a food within the meaning of this Act..the ingredients, other than dietary ingredients under section 201(ff) [vitamin, mineral, herb or botanical, amino acid ] of the act, be lawful under the applicable food additive regulations or be generally recognized as safe (GRAS) 3 Conformance to Dietary Supplement Compendial Monographs Dietary Supplement Health and Education Act of 1994 (DSHEA), Sec. 7(a)(1)(D) A dietary supplement may be misbranded if it states conformance to a compendial monograph but does not conform. 4 2

Use of Excipients in Dietary Supplements Data widely known may be used to form a basis for a consensus among experts that use of an excipient in a dietary supplement is safe. However, the use of excipients in drugs may be short term or intermittent, leading to far less exposure than routine use in some dietary supplements. As human exposure increases, not only does the safety profile of the intended excipient become more important, but the purity specifications also become more critical. FDA Response, Comment 239, Federal Register, Vol. 72, No. 121, June 25, 2007, 21CFR Part 111 Final Rule 5 WHY is this important? There is confusion among some dietary supplement companies about whether ingredients should be food grade or excipient grade The USP is leading supplement manufacturers to believe that only USP or NF ingredients should be used Whats impacted: Customer and supplier agreements regarding product grades, specifications, quality/gmp systems and costs Expectations under the USP Verified Dietary Supplements certification Potential regulatory compliance issues for ingredients 6 3

WHAT is being done about it? Our trade associations are: Ø Communicating with FDAs Office of Food Additives and other departments in the Agency to continue support for FDAs position on the use of food additives in supplements Ø Submitting comments to FDA proposed rules and guidances under FSMA and other regulations to ensure food additives are included and/or differentiated appropriately Ø Engaging USP to clarify their position Ø Added wording to USP Convention Resolution 9: Quality Standards for Dietary Ingredients and Dietary Supplements 7 WHY is this important to USP <2232> Elemental Contaminants in Dietary Supplements? USP <2232> : Is mandatory for supplements that have compendial monographs Requires knowledge of the potential for elemental contaminants contributed by ingredients Ingredient monographs generally do not have specifications for the elements in <2232> or if they do, they are based on non-quantitative limit tests Suppliers of ingredients generally dont have data on these elements! 8 4

USP Elemental Impurities History ICH and USP have developed guidelines and general chapters related to Elemental Impurities in drug products USP also has a chapter for Elemental Contaminants in Dietary Supplements <2232> Ø Official August 1, 2013 but General Notices 5.60.30 Elemental Impurities in USP Drug Products and Dietary Supplements establishes January 1, 2018 for applicability of chapter <2232> unless specified otherwise in a monograph Ø Early adoption of <2232> is permitted Ø <233> Elemental Impurities Procedures becomes official December 1, 2015 Ø General Chapter <231> Heavy Metals will be removed from the USP 9 USP FAQs (Jan 24, 2015)* Current heavy metals limit test <231> is >100 yrs old, does not speciate elements and may not detect certain elements such as Hg at toxicologically-relevant levels <2232> Establishes limits of acceptable levels of elemental impurities (Pb, Hg, As, Cd) in dietary supplements Methodology in <233> includes procedures that use modern analytical technology As more ingredients are sourced globally these standards are expected to protect manufactures and consumers in the US As Hg Cd Pb * http://www.usp.org/usp-nf/key-issues/elemental-impurities 10 5

USP <2232> Elemental Contaminants in Dietary Supplements Applies ONLY to finished dietary supplements dosage forms labeled as conforming to USP or NF standards Does NOT set limits for dietary supplements. If applicable, limits are set in the individual monographs Focuses on the big 4: arsenic, cadmium, lead and mercury Extent of testing is determined based on a risk-based approach Takes into account the likelihood of contamination Manufacturers should consider the presence of unexpected elemental contaminants to determine compliance 11 Options for Compliance with the Limits of Elemental Contaminants Option 1 Dietary Supplement Analysis Option Option 2 Individual Component Option Option 3 Summation Option 12 6

<2232> Options 1 & 3 Option 1: Dietary Supplement Analysis Finished dosage form is analyzed according to methods in <233> or speciation procedures given in <2232> Acceptance criteria: results are not more than the PDE Option 3: Summation Finished dosage forms that are consumed in quantities >10 g/day or where the acceptance limit for any contaminant in any component of the supplement exceeds the applicable individual component limits Unless otherwise specified in the individual monograph, use the procedures in <2232> Acceptance criteria: amount of each component /daily intake is not more than the PDE 13 <2232> Options 1 & 3 Limits Element Arsenic (inorganic) 15 Cadmium 5 Lead 5 Mercury (total) 15 Methylmercury (as Hg) 2 PDE (µg/day) Methylmercury determination is not necessary when the content for total mercury is less than the limit for methylmercury 14 7

<2232> Option 2 & Limits Option 2: Individual Component Option Applicable to finished dosage forms with a max. daily intake of NMT10 g of the finished supplement product Unless othewise specified in the individual monograph use the procedures in <2232> Acceptance criteria: each component meets the limits below Element Individual Component Limits (µg/g) Arsenic (inorganic) 1.5 Cadmium 0.5 Lead 0.5 Mercury (total) 1.5 Methylmercury (as Hg) 0.2 Methylmercury determination is not necessary when the content for total mercury is less than the limit for methylmercury 15 How to Determine Which Option to Use? Appropriate control of elemental contaminants must be based on risk but also take into consideration the challenges faced by industry in implementing these requirements. How do you do this? What role will data vs information play in this? Where to find solid and appropriate data today? How do you evaluate risk? Without reliable information on components you will test everything or simply default to Option 1 Product Testing 16 8

Sources of Potential Contamination Focus is on the final product but consider the components Dietary Ingredient Active Utilities (e.g. Water) Inactive Ingredients Dietary Supplement Product Manufacturing Equipment Primary Packaging Materials 17 Sources of Potential Elemental Contaminants Solvents Water Metal Catalysts Elemental Contaminants in DS Organic Materials Mfg. Equip. Inorganic Reagents Process Aids How can data assist in classifying risk? Deliberately added metal catalysts Water monitoring Equipment construction of materials; GMP/ inspection Solvents few utilize metals deliberately in manufacture. Many are distilled 18 9

How to Evaluate & Control Potential Elemental Contaminants Dietary supplement manufacturing often involves a complex series of processes, however: Simple scientific principles can be applied to ensure that elemental contaminants in the final product are controlled to appropriate levels Application of a risk-based control strategy: Ø Ø Ø Understand the manufacturing process and key sources of elemental contaminants focusing on critical later stages Appropriate equipment selection/qualification Adoption of suitable GMPs and the selection and application of appropriate controls will typically result in the manufacture of the dietary supplement with elemental contaminant levels well below USP limits 19 Risk of Potential Elemental Contaminants in Ingredients Mined (e.g. talc) Synthesized with Metal Catalyst (e.g. mannitol) Plant Origin (e.g. cellulose derivatives) Animal Origin (e.g. lactose & gelatin) Increasing Potential Risk of Contributing Elemental Contaminants Synthesized without Metal Catalyst (e.g. colloidal SiO 2 ) 20 10

Potential Sources of Elemental Contamination from Ingredients Ø Many are from natural sources anticipate variability Ø Contaminants often inherent due to sourcing & can not be easily reduced or removed Plant-derived ingredients Synthetic ingredients Grown in soil (e.g. cellulose derivatives) Harvested from the ocean (e.g. alginates, carrageenan) Derived from oil through synthetic processes may use metal catalysts (e.g. povidone, PEG, silicones) Mineral-based ingredients Conversion of ores from mines (e.g. TiO2) 21 Hmmm I wonder what the lead level is Here and Here and Here 22 11

And Here 23 Kaolin mine near Kaznejov, Czech Republic Known at least 12 to 55 ppm Lead from periodic testing FCC lead spec NMT 10 ppm Talc extraction in Trimouns Talc Mine, Midi-Pyrenees, France Known only tested once per year FCC lead spec NMT 5 ppm 24 12

Excursions - Potential Normal Variation Many impurities are naturally present (e.g. lead) in mined raw materials and cannot be further processed out; therefore, it is important to understand the actual levels present Normal variation can be expected from excursions that occur in the raw material source 25 Elemental Contaminant Realities Today little data exists to perform a scientific risk assessment of elemental content Unknown Unknowns Specifications, where they exist, for the 4 elements have been largely based on limit tests Most ingredients have not been routinely tested using quantitative methods; therefore, current elemental concentrations and variability is often UNKNOWN! Communication between the supplement manufacturers and suppliers is critical to best understand what is known and NOT known about levels in ingredients Lack of industry data required to confirm actual vs theoretical metal impurity levels It will take a long time to develop enough data to understand normal variation needed for a science-based risk assessment 26 13

Key Analytical Challenges for Industry Analytical testing required to quantify elemental contaminants in dietary supplements down to the levels in USP <2232> Current work indicates that analytical challenges may be greater than previously anticipated by regulators and pharmacopeias. Labs are finding ICP-MS testing to be much more complex than previously thought Complexity of samples Adapting to ICP-MS analysis Existing spectroscopy labs adapting to the requirements of <233> 27 Technical Challenges ICP-MS analysis requires specialized experience: Maintenance/operation Interference interpretation & remediation Chemical incompatibilities with analytes Use of internal standards, reaction gases, correction equations, etc Sample preparation concerns: Variety of samples Aggressive microwave digestions Total digestion vs acid leach methods High dissolved solids, acid concentrations, incomplete digestions, etc No appropriate reference standards available for assessing inter-laboratory variation 28 14

Analysis by Industry and FDA Labs IPEC and FDA* labs analyzed 200+ samples of excipients. The data generated to date is encouraging BUT some caution is needed. Ø At this stage we have only cursory knowledge relating to the level of variability especially for naturally sourced materials Ø The limited number of samples tested can not as yet represent what types of excursions may be possible Ø This will only really be known after much more testing over a period of time Ø How much data is needed? * John Kauffman, Rapporteur and Regulatory Chair, ICH Q3D IWG, Lab Chief, Branch II, FDA, CDER Division of Pharmaceutical Analysis 29 Study Conclusions Data for standardized samples show high variation across laboratories Flexibility and further evaluation needed in methodology for testing labs Overall the risk of elemental contaminants in the final dietary supplement is going to be low in most cases The more data we can collect and interpret the closer we can get to achieving practical implementation differentiated and focused on actual rather than perceived risk. 30 15

What Should Your Company Do NOW? Determine which <2232> Option is appropriate for your products based on knowledge of the ingredients and finished product - Complete initial assessment for each ingredient as needed - If appropriate, develop baseline levels for each ingredient used in a dietary supplement product where necessary, monitor for excursions Establish / validate equipment (ICP-AES/ICP-MS) or identify external test facility Develop sample preparation and analysis methodologies Train personnel Collaboratively work together (supplement manufacturers / ingredient suppliers) to develop (via risk assessment) testing / reporting strategy January 1, 2018 is fast-approaching!! 31 Sharing Information between Suppliers and Customers Use information, where available, from ingredient suppliers to determine potential presence / concentration of each metal (and the potential for excursions) used in the production of dietary supplements and in the assessment of a finished dietary supplement Permitted Daily Exposure (PDE) level. 32 16

BUT Remember. Unknown is an acceptable answer from suppliers Testing for ingredients by the suppliers is not required unless otherwise specified in the ingredients compendial monograph Ingredients in dietary supplements are not subject to the limits in <2232> or <232> (drug products) So.be prepared to consider multiple options to achieve product compliance! 33 Thank You! Acknowledgements Katherine Ulman Dow Corning David Schoneker Colorcon Andrew Teasdale Astra Zeneca Helmut Rockstroh Roche John Kauffman FDA, CDER 34 17

Questions? 35 36 18